SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudeep Pharma lists at 24% premium on the BSE

28 Nov 2025 Evaluate

Sudeep Pharma has debuted at Rs 733.95 on the BSE, up by 140.95 points or 23.76% from its issue price of Rs 593.00.

The scrip is currently trading at Rs. 759.25, up by 166.25 points or 28.03% from its issue price.

It has touched a high and low of Rs. 762.00 and Rs. 726.00 respectively. So far 15.84 lakh shares were traded on the counter.

The offering, which was open for subscription between November 21, 2025 and November 25, 2025 was subscribed 93.71 times. The issue price was fixed at Rs 593.00 per share i.e. at upper end of price band of Rs 563-593 apiece.

Sudeep Pharma is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem.

Sudeep Pharma Share Price

610.30 -3.45 (-0.56%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×